menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

European health agency recommends approving Moderna's combined flu, COVID vaccine

16 0
27.02.2026

European health agency recommends approving Moderna’s combined flu, COVID vaccine

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time the combined respiratory viral vaccine will be approved.

“EMA has recommended granting a marketing authorisation in the European Union (EU) for mCombriax, a messenger RNA vaccine for protecting people aged 50 years and older against COVID-19 and seasonal influenza (flu),” the EMA said in a statement.

Moderna began developing its combined COVID and flu vaccine, called mCombriax, in 2021, reporting positive results from Phase 3 trials in 2024. Full authorization will also make this the first mRNA flu shot approved globally.

“The CHMP’s [EMA’s Committee for Medicinal Products for Human Use] positive opinion represents an important milestone for respiratory virus vaccination and for Moderna, with the introduction of the world’s first flu plus COVID combination vaccine. If approved, this would be Moderna’s fourth marketed product in Europe,” Moderna CEO Stéphane Bancel said in a press release.

“Combination vaccines have the potential to simplify vaccination and support improved health outcomes. We appreciate the EMA’s rigorous scientific review.”

In the U.S., progress toward approval stalled last year when Moderna announced it had voluntarily pulled its submission for the combined COVID and flu vaccine. The company recently faced a hurdle regarding its mRNA flu vaccine candidate when the Food and Drug Administration refused to review its application, before the agency reversed this decision a week later.

The EMA’s recommendation does not mean the vaccine will hit the European market just yet. As the agency noted, the recommendation must now go to the European Commission for the adoption of a decision on an EU‑wide marketing authorization.

Copyright 2026 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More Health Care News

Trump floats ‘friendly takeover’ of Cuba

Pentagon removes director of Joint Staff, sends him back to Navy role

Democratic senator presses Noem on suspension of global entry, TSA PreCheck

The big new controversy over the Epstein files, explained

GOP senators warn Justice Department to release all Epstein files mentioning ...

Trump administration urges Supreme Court to end temporary protections for ...

The 22nd Amendment at age 75: is it seriously under challenge?

‘I did nothing wrong’: Bill Clinton denies knowledge of Epstein abuse in ...

Rove: Trump made ‘key mistake’ during State of the Union

Democrat calls Noem meeting ‘heated and tense’ after call for impeachment

Senate Democrats demand tariff refunds begin ‘immediately’

O’Reilly calls on DOJ to ‘make an example’ of De Niro

Megan Rapinoe: I would have never allowed Kash Patel in locker room

Trump says he’s not considering declaring a national emergency ahead of ...

Whitmer says US-Canada bridge Trump threatened to block ‘will open’

Former Trump surgeon general: ‘Incomprehensible’ Senate is considering Means

Senate Democrat: Trump pick ‘not qualified’ to lead National Security Agency

Democrats fume after Boebert leaks deposition photo of Hillary ...


© The Hill